In a double-blind, placebo-controlled study, researchers investigated the effects of PEMF on migraine activity among 42 subjects who met the criteria for migraine according to the International Headache Society. The treatment involved applying PEMF to the inner thighs for one hour per day, five days per week, over a period of two weeks.
During the first month of follow-up, 73% of those who received actual PEMF reported decreased headaches, with 45% reporting a good decrease and 14% an excellent decrease. In contrast, only a small percentage of the placebo group reported decreased headaches, with 20% reporting a good decrease and none reporting an excellent decrease; 15% even reported worse headaches.
Additional findings showed that among the subgroup who received an extra two weeks of PEMF treatment after the initial follow-up, all experienced decreased headache activity, with 50% reporting a good decrease and 38% an excellent decrease.
Conversely, among those who opted not to receive additional treatment, 12 out of 13 still showed decreased headache activity by the second month, with 29% reporting a good decrease and 43% an excellent decrease.
PubMed ID: 11279973